The parenteral route of administration is the most effective route for the delivery of the active pharmaceutical substances with narrow therapeutic index, poor bioavailability especially for those drugs, prescribed to unconscious patients. To maintain a therapeutic effective concentration of the drug, it requires frequent injections which ultimately lead to patient discomfort. In parenteral drug delivery, major progress has been done in the field of formulation technologies so as to provide a targeted and sustained release of drug in predictable manner. The present article reviews recent patents and major advancements in parenteral drug delivery systems along with general introduction. This article also deals with importance of novel systems in drug delivery to overcome the problems
INTROUCTION
The term parenteral is derived from two Greek words para means outside, enteron means together, these are intended injection of the drugs through the skin, not rather than alimentary canal, so that active ingredients are administered directly into blood vessel or tissue or organ by using force of gravity 1 .
Advantages:
 It provides rapid onset of action.
 It provides immediate therapeutic action.
 It can be administered accurate dose.
 It can be given to patient who cannot take oral medication.
 It minimises the first pass effect.
 It provides more bioavailability 2 .
Disadvantages:
 It should be administered aseptically.
 It provides pain at the site of injection.
 The administration of drug through wrong route may provide fatal effect.
 Self-administration is not possible. 
EVALUATION OF PARENTERALS:
The following are the evaluation test for the parenteral. They are as follows. Volume of the medium must be sufficient to promote and expedite microbial growth.
Adequate mixing between the sample inoculum and the culture medium must take place to maximise interaction and facilitate microbial growth.
b.Membrane filtration method (MF):
The steps involved in MF sterility test method are 1. The filter unit must be properly assembled and sterilised prior to use.
2. The contents are transferred to the filter assembly under strict aseptic conditions.
3. The membrane is removed aseptically.
4. Membrane is cut in half.
One half is place in suitable volume of FTM
and another in an equal volume of TSB.
Interpretation of results:
1. If there is no visible evidence of microbial growth, it may be interpreted that the sample is without intrinsic contamination.
2.
If microbial growth is found the sterility test may be repeated.
Clarity test (particulate matter evaluation)
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1. Particulate matter in parenteral solutions has been recognized as anacceptable. Since the user could be expected to conclude that the presence of visible dirt would suggest that the product is of inferior quality.
2.
The entire product should be inspected by human inspectors under good light baffled against reflection into the eye and against black and white background.
3. Any container with visible particle if seen is discarded.
4.
Size of the particle that can be seen only be observed by using clarity test apparatus.
3.Leakers test: [containers or closures integrity test]
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 Ampules sealed by fusion are subjected for leakers test. 
Mechanism of LAL test:
Primitive blood clotting mechanism of horse shoe crab
Enzymes located with the crabs amoebocyte blood cells endotoxins
Initiation of an enzymatic coagulation cascade
Proteinaceous gel
